Sentinel lymph node detection for lung cancer surgery: a possible pathological surrogate of overall lymph node dissection.

Fiche publication

Date publication

mars 2025

Journal

Frontiers in oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GAUCHOTTE Guillaume , Dr STREIT Arthur

Tous les auteurs :
Stasiak F, Seitlinger J, Walsh LC, Streit A, Siat J, Gauchotte G, Schnedecker L, Renaud S

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40161369

Résumé

Systematic lymph node dissection (SLND) is currently the gold standard for lung cancer surgery. However, this is not the case for breast cancer or melanoma, where sentinel lymph node (SLN) identification is routine. The SLN could be a possible surrogate for the pathological status of the other lymph nodes, but there is limited data in the literature for lung cancer surgery. The main objective of this study was to evaluate pathological concordance between the SLN and the complete lymphadenectomy.